Budget Impact of Apomorphine Sublingual Film for On-Demand Treatment of Patients With Parkinson's Disease and "OFF" Episodes

被引：0
|
作者：
Thach, A. [1 ]
Kirson, N. [1 ]
Zichlin, M. [1 ]
Dieye, I. [1 ]
Pappert, E. [1 ]
Williams, G. [1 ]
机构：
[1] Sunovion Pharmaceut Inc, Marlborough, MA USA
来源：
MOVEMENT DISORDERS | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
958
引用
收藏
页码：S427 / S427
页数：1
相关论文
共 50 条
  • [31] Efficacy of Sublingual Apomorphine (APL-130277) for the Treatment of "Off" Episodes in Patients with Parkinson's Disease
    Hauser, Robert A.
    Dubow, Jordan
    Dzyngel, Bruce
    Bilbault, Thierry
    Giovinazzo, Anthony
    Shill, Holly
    Agro, Albert
    ANNALS OF NEUROLOGY, 2015, 78 : S44 - S44
  • [32] Comparative bioavailability of apomorphine sublingual film and subcutaneous apomorphine formulations in patients with parkinson's disease and "OFF" episodes: preliminary results
    Agbo, F.
    Isaacson, S.
    Ellenbogen, A.
    Gil, R.
    Bhargava, P.
    Navia, B.
    Blum, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 445 - 445
  • [33] Efficacy of sublingual apomorphine (APL-130277) for the treatment of "Off" episodes in patients with Parkinson's disease
    Hauser, R. A.
    Dubow, J.
    Dzyngel, B.
    Bilbault, T.
    Giovinazzo, A.
    Agro, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 249 - 249
  • [34] Safety of Sublingual Apomorphine (APL-130277) for the Treatment of OFF Episodes in Patients with Parkinson's Disease
    Isaacson, Stuart
    Dubow, Jordan
    Dzyngel, Bruce
    Bilbault, Thierry
    Giovinazzo, Anthony
    Agro, Albert
    ANNALS OF NEUROLOGY, 2015, 78 : S47 - S47
  • [35] Safety and Tolerability of Apomorphine Sublingual Film During Maintenance Treatment in Patients With Parkinson's Disease and "OFF" Episodes: A Pooled Analysis
    Ondo, W.
    Ellenbogen, A.
    Isaacson, S.
    Espay, A.
    Singer, C.
    Bhargava, P.
    Worden, M.
    Blum, D.
    Navia, B.
    MOVEMENT DISORDERS, 2019, 34
  • [36] Long-term Safety and Tolerability of Apomorphine Sublingual Film in Patients with Parkinson's Disease and "OFF" Episodes
    Ondo, William
    Ellenbogen, Aaron L.
    Isaacson, Stuart
    Espay, Alberto J.
    Bhargava, Parul
    Worden, MaryAlice
    Blum, David
    Navia, Bradford
    NEUROTHERAPEUTICS, 2019, 16 (03) : 913 - 913
  • [37] Apomorphine sublingual film versus subcutaneous apomorphine in the treatment of OFF episodes in Parkinson's disease: results from an assessment of patient satisfaction
    Schwarz, J.
    Carroll, C.
    Ebersbach, G.
    Kulisevsky, J.
    Tessitore, A.
    Zhang, I.
    Bowling, A.
    Wu, S.
    Pappert, E.
    Thach, A.
    MOVEMENT DISORDERS, 2022, 37 : S352 - S352
  • [38] A Long-Term Safety, Tolerability, and Efficacy Study of Apomorphine Sublingual Film for On-Demand Treatment of "OFF" Episodes in De Novo vs Rollover Patients With Parkinson's Disease: Interim Results
    Pahwa, R.
    Fox, S.
    Singer, C.
    Bhargava, P.
    Navia, B.
    MOVEMENT DISORDERS, 2020, 35 : S411 - S411
  • [39] On-Demand Therapy for OFF Episodes in Parkinson's Disease
    Olanow, C. Warren
    Poewe, Werner
    Rascol, Olivier
    Stocchi, Fabrizio
    MOVEMENT DISORDERS, 2021, 36 (10) : 2244 - 2253
  • [40] APOMORPHINE SUBLINGUAL FILM DOES NOT WORSEN DYSKINESIA IN THE LONG-TERM TREATMENT OF "OFF" EPISODES IN PARKINSON'S DISEASE
    Klos, K. J.
    Hui, J. S.
    Zhang, I.
    Navia, B.
    Pappert, E.
    PARKINSONISM & RELATED DISORDERS, 2023, 113 : 42 - 42
12345